17Oct 2024
SGA Therapy Modulates Immune Markers in Schizophrenia Patients

SGA Therapy Modulates Immune Markers in Schizophrenia Patients

Second-generation antipsychotics (SGA) may influence immune responses in schizophrenia by down-regulating IFN-γ levels, potentially enhancing patient comfort. An analysis of 156 patients, including those on SGA monotherapy and combined therapy, found no significant changes in cytokines or lymphocyte proportions after treatment. The results indicate that while SGA monotherapy affects IFN-γ, combined therapy closely mirrors monotherapy's effects, highlighting the need for further exploration in immune interactions.

  • #psychiatry

Like

Save

Share